Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Targeted Oncology

Issue 1/2012

Special focus on immunotherapy

Content (7 Articles)

Editorial

Recent successes of cancer immunotherapy: a new dimension in personalized medicine?

Christophe Caux, Laurence Zitvogel

Review

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

F. Jotereau, N. Gervois, N. Labarrière

Review

Targeting regulatory T cells

Christine Ménétrier-Caux, Tyler Curiel, Julien Faget, Manuarii Manuel, Christophe Caux, Weiping Zou

Review

Targeting pattern recognition receptors in cancer immunotherapy

Nadège Goutagny, Yann Estornes, Uzma Hasan, Serge Lebecque, Christophe Caux

Open Access Review

Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival

Michel Morre, Stéphanie Beq

Review

A review on various targeted anticancer therapies

Junjie Li, Feng Chen, Marlein Miranda Cona, Yuanbo Feng, Uwe Himmelreich, Raymond Oyen, Alfons Verbruggen, Yicheng Ni

Review

Advancement in the research on vascular endothelial growth inhibitor (VEGI)

Lijiao Duan, Ganggang Yang, Ruigang Zhang, Lijuan Feng, Cunshuan Xu

Mar 12
Issue: Special Issue 1/2012
Special focus: Biosimilars
Jun 12
Issue: 2/2012
Special focus: Neuroendocrine tumors Part I

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits